Working Group on AIDS and Drug Addiction
Good Pharmacy Practice Seminar
Assembly of Pharmacists and Pharmaceutical Scientists
Work-symposium: Consultancy in the Pharmacy
Radiopharmaceuticals for Diagnosis and Therapy
Working Group, History of Pharmacy
Tuesday, 2 September
Working Group on AIDS and Drug Addiction
09.00-12.00
I - AIDS Report
drawing up of the situation of AIDS epidemic in the main geographical areas of the world (Europe, America, Africa and Asia)
presentation of some examples of actions by pharmacists from all over the world
II - Institutions
WHO: the strategy of WHO with regard to epidemiology; the role of the different health professions
FIP: what is the role of pharmacists in the fight against HIV - AIDS the role of pharmacists in the different countries of the world information to the general public
III - Pharmaceutical Charter on AIDS
formal adoption of an international charter defining the participation of the pharmacists in the fight against HIV - AIDS
Good Pharmacy Practice Seminar
13.30-16.45
Chair: Nils-Olof Strandqvist, Sweden
13.30-13.45 Introduction
13.45-14.15 Report on the survey of the world-wide implementation work of the GPP - thoughts
14.15-14.45 New trends in society influencing the GPP
14.45-15.15 Break
15.15-15.45 GPP - seen from the medical side
15.45-16.45 Doctors - pharmacists; - the future collaboration to the benefit of the patient
Wednesday, 3 September
Assembly of Pharmacists and Pharmaceutical Scientists
10.00-12.00 The Assembly is the major opportunity for individual members of FIP to take part in policy formation within FIP. The FIP President, Dr. Dieter Steinbach, will report on the work of FIP. In particular there will be the opportunity to discuss a number of draft statements which are in preparation within FIP. The views of individual pharmacists and pharmaceutical scientists are important when the Council of FIP debate the statement before deciding whether to adopt it or not. The 1997 Assembly will have simultaneous interpretation in English, French, German and Spanish. This is primarily a working session where interaction between attendees will be given a high priority.
09.00-12.00 Cancer Prevention and Early Detection
Chair: Jim Koeller, USA
(Sponsored by an educational grant from Hoechst Marion Roussel)
Breast cancer prevention and detection Max Summerhayes, UK
Colorectal cancer prevention and detection Jeff Barnette, Canada
Skin cancer prevention and detection Jude Lees, Australia
Prostate cancer prevention and detection Rebecca Finlay, USA
14.00-17.00 Pharmacy students of today are the pharmacists of tomorrow
Pharmacy students and pharmacists are once again invited to attend the FIP/IPSF Students Day. The objective is to introduce students to current trends in international pharmacy and to allow interaction between pharmacists and pharmacy students.
As the pharmaceutical profession is in a constant state of change, it is important that pharmacists and pharmacy students are made aware of the new opportunities facing the profession.
Does pharmaceutical education meet the needs of the profession and/or is the profession keeping up with the changes in education? During this session ideas and opinions will be discussed, and participants will have the opportunity to listen to prominent members of the pharmaceutical profession talking about current international trends in pharmacy and the impact of these changes at student and professional levels. There will be an evening function where students and pharmacists have the opportunity to minimise the generation gap.
Students wishing to register for this in advance, please contact:
President IPSF, Andries Bickerweg 5, 2517 JP The Hague, The Netherlands
Students will receive a free pass which will entitle them to attend any other FIP-session on Wednesday. Please register in advance.
Open Forums
14.00-17.00 Working Group on Managed Care
Chair: Albert Wertheimer, USA
Objectives
In 1996 FIP established a working group to study managed care and its impact on pharmacy. This working group has reviewed the international literature and has interviewed knowledgeable persons within and outside of pharmacy. While the final report will be presented in 1998 in Cairo, this is an opportunity for FIP members to both hear about the workings of the working group and listen to an update of the interim findings and conclusions.
In addition, this is a splendid opportunity for pharmacists to provide their input to the panel, from their experiences, thoughts and readings, or just to ask a question. The process will be enriched through as much participation as possible.
Managed care pharmacy involves some or all of the following: formularies, prospective and retrospective drug utilisation review (DUR), network of dispensing pharmacies, discount negotiations, provider profiling, benefit design modifications and outcomes related disease state management techniques.
Work-symposium: Consultancy in the Pharmacy
14.00-17.00
(Sponsored by an educational grant from Procter & Gamble Healthcare)
Objective:
Procter & Gamble Healthcare are pleased to continue, for the fourth year, their sponsorship of the series of symposia entitled:
"Effective Patient Management in the Pharmacy".
The continued focus of the series will be to provide the Community Pharmacist with the scientific and medical information necessary to arrive at a reasoned decision on optimum medication recommendation. The format that was successfully used in 1996 will be repeated in 1997 as 94% of the audience found this format either extremely/very enjoyable or enjoyable. At the time of going to press the precise title has not been agreed but it will be a subject relevant to the practice of pharmacy in the community.
Thursday, 4 September
FIP/Special Interest Group
09.00-11.00 Radiopharmaceuticals for Diagnosis and Therapy
Chair: Leonard Weibe, Canada
Gene Therapy
Fundamental concepts of gene therapy will be described followed by practical applications of diagnostic radiopharmaceuticals for monitoring gene transfection and transduction in gene therapy in cancer
Speakers to be announced
11.00-13.00 Radiopharmaceuticals for Diagnosis and Therapy
Chairs: A. Noujaim, Canada and Stanley Shaw, USA
Radiolabelled Peptides and Antibodies
Concepts and applications of radiolabelled peptides and antibodies for the detection of disease, treatment planning and monitoring therapeutic outcomes will be addressed.
Speakers to be announced
Working Group, History of Pharmacy
09.00-12.00 As in previous years, FIP will provide a platform to the International Society of the History of Pharmacy to organise a special symposium.